Paid Clinical Trials Wilmington

Discover 131 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 131

BMS-986278A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Wilmington NC, Durham NC, Charleston SC, Rock Hill SCshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

RitlecitinibA 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Wilmington NC, Chapel Hill NC, Charleston SC, Largo MDshow 23 more

Code:

NCT06163326

Conditions

Vitiligo

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Ritlecitinib 100 mg

Placebo

Budesonide, Glycopyrronium, FormoterolA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Wilmington NC, Morehead City NC, Fayetteville NC, Greenville NCshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

BRIUMVIA Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)

Recruiting

Sponsor:

TG Therapeutics, Inc.

Location:

Wilmington NC

Code:

NCT06433765

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: Female

Age: 15 - 50

Healthy Volunteers: Not accepted

Interventions

No intervention

CrizotinibCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Jacksonville NC, Kenansville NC, Richlands NC, Clinton NCshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis

Osimertinib & BevacizumabOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Jacksonville NC, Kenansville NC, Richlands NC, Clinton NCshow 422 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

SonelokimabEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Leland NC, Salisbury NC, Statesville NC, Beckley WVshow 21 more

Code:

NCT06641076

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Elagolix & ContraceptivesStudy Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Wilmington NC, New Bern NC, Durham NC, Summerville SCshow 133 more

Code:

NCT04333576

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

Elagolix

Placebo

Combined Oral Contraceptive

ColonoscopyFive or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting

Sponsor:

NRG Oncology

Location:

Jacksonville NC, Clinton NC, Goldsboro NC, Charleston SCshow 297 more

Code:

NCT05080673

Conditions

Adenocarcinoma of the Colon

Adenocarcinoma of the Rectum

Eligibility Criteria

Sex: All

Age: 50 - 70

Healthy Volunteers: Not accepted

Interventions

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

Neratinib & PalbociclibTesting the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Jacksonville NC, Clinton NC, Goldsboro NC, Raleigh NCshow 111 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging